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Iron-sulfur proteins are among the primary targets of nitric
oxide in cells. Previous studies have shown that iron-sulfur clusters hosted by cysteine residues in proteins are readily disrupted
by nitric oxide forming a protein-bound dinitrosyl iron complex, thiolate-bridged di-iron tetranitrosyl complex, or octanitrosyl cluster. Here we report that human mitochondrial protein
Miner2 [2Fe-2S] clusters can bind nitric oxide without disruption of the clusters. Miner2 is a member of a new CDGSH ironsulfur protein family that also includes two mitochondrial proteins: the type II diabetes-related mitoNEET and the Wolfram
syndrome 2-linked Miner1. Miner2 contains two CDGSH
motifs, and each CDGSH motif hosts a [2Fe-2S] cluster via three
cysteine and one histidine residues. Binding of nitric oxide in
the reduced Miner2 [2Fe-2S] clusters produces a major absorption peak at 422 nm without releasing iron or sulfide from the
clusters. The EPR measurements and mass spectrometry analyses further reveal that nitric oxide binds to the reduced [2Fe-2S]
clusters in Miner2, with each cluster binding one nitric oxide.
Although the [2Fe-2S] cluster in purified human mitoNEET and
Miner1 fails to bind nitric oxide, a single mutation of Asp-96 to
Val in mitoNEET or Asp-123 to Val in Miner1 facilitates nitric
oxide binding in the [2Fe-2S] cluster, indicating that a subtle
change of protein structure may switch mitoNEET and Miner1
to bind nitric oxide. The results suggest that binding of nitric
oxide in the CDGSH-type [2Fe-2S] clusters in mitochondrial
protein Miner2 may represent a new nitric oxide signaling mode
in cells.

Iron-sulfur clusters in proteins are often hosted by cysteine
residues, although histidine, glutamine, serine, or arginine can
also be the ligands (1, 2). Recently, a new group of iron-sulfur
proteins that contain one or two CDGSH motifs have been
identified in eukaryotes, archaea, and several bacteria (3). A
common feature of the CDGSH proteins is that they host one or
two [2Fe-2S] clusters via an unusual ligand arrangement of
three cysteine and one histidine residues (3). In human mito-
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chondria, there are three CDGSH iron-sulfur domain (CISD)2
proteins: mitoNEET (CISD1) (4), Miner1 (mitoNEET-related
protein 1, CISD2, or NAF-1) (5, 6), and Miner2 (mitoNEETrelated protein 2, CISD3) (7). MitoNEET, a target of the type II
diabetes drug pioglitazone (4), localizes on the mitochondrial
outer membrane and exists as a homodimer (7). Each monomer
of mitoNEET contains a CDGSH motif that hosts one [2Fe-2S]
cluster (8 –10). Miner1 has 54% identity and 76% similarity with
mitoNEET (5) and also localizes on the mitochondrial outer
membrane (11). Like mitoNEET, each monomer of the Miner1
homodimer contains a CDGSH motif that hosts one [2Fe-2S]
cluster (5). Mutation of Miner1 has been attributed to causing
Wolfram syndrome 2, a disease characterized by juvenile-onset
diabetes mellitus and optic atrophy (12). Both mitoNEET and
Miner1 have central roles in regulating iron homeostasis,
energy metabolism, and production of free radicals in mitochondria (11, 13). Recent studies further suggested that
mitoNEET may transfer its [2Fe-2S] clusters to target proteins
in the cytoplasm (14, 15) or directly regulate mitochondrial
functions via the redox transition of the [2Fe-2S] clusters (16 –
18). Miner2 contains an N-terminal mitochondrial signal peptide and two CDGSH motifs. Although mitochondrial Miner2
is found to be highly expressed in lung cancer, breast cancer,
and other types of cancer (Cancer Browser), it has not been
purified or characterized previously, and very little is known
about the function of Miner2 in mitochondria. Nevertheless,
the crystal structure of the Miner2 homolog from Magnetospirillum magneticum shows that Miner2 is a monomer that hosts
two [2Fe-2S] clusters via two CDGSH motifs in an internal
pseudodyad symmetry (3).
Ironically, iron-sulfur clusters are among the primary targets
of the physiological free radical nitric oxide, as nitric oxide has
a strong reactivity with ferrous iron in proteins (19). In bacteria,
nitric oxide regulates global gene expression via direct modification of iron-sulfur clusters in several transcription factors
(20 –24). At high concentrations, nitric oxide inhibits bacterial
cell growth by disrupting iron-sulfur clusters in multiple
enzymes (21, 25, 26). In mitochondria, nitric oxide has been
shown to modulate energy metabolism by interacting with
iron-sulfur clusters and hemes in proteins (27). For example,
nitric oxide directly modifies the [4Fe-4S] cluster in mitochondrial aconitase and blocks the citric acid cycle (28). Among the
reported examples so far, iron-sulfur clusters in proteins are all
2
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Results
Human Miner2 [2Fe-2S] Clusters Have a Unique Interaction
with Nitric Oxide—The recombinant human mitochondrial
CDGSH proteins mitoNEET, Miner1, and Miner2 were prepared from Escherichia coli cells as described under “Experimental Procedures.” Fig. 1A shows that purified human
mitoNEET, Miner1, and Miner2 had a similar UV-visible
absorption spectrum, with two major absorption peaks at 458
and 550 nm, indicative of the oxidized [2Fe-2S] clusters in each
protein (35). When purified proteins were reduced with dithiothreitol under anaerobic conditions (17), mitoNEET and
Miner1 had an identical EPR spectrum with g ⫽ 1.94 of the
reduced [2Fe-2S] clusters (Fig. 1B), as reported previously (35,
36). This is likely because mitoNEET and Miner1 have 54%
identity and 76% similarity (5). In contrast, the reduced Miner2
appeared to have two overlapping EPR spectra (Fig. 1B). Deconvolution of the EPR spectrum of the reduced Miner2 produced
two distinct EPR spectra with g ⫽ 1.92 and g ⫽ 1.94, respectively (Fig. 1C), suggesting that human Miner2, like the Miner2
homolog from M. magneticum (3), hosts two [2Fe-2S] clusters
via two CDGSH motifs.
As the redox midpoint potential (Em7) of the [2Fe-2S] cluster
in mitoNEET is about 0 mV (37), the CDGSH-type [2Fe-2S]
clusters in proteins are most likely in a reduced state in cells
under normal physiological conditions (17). To explore the
interaction between the mitochondrial CDGSH proteins and
nitric oxide, purified mitoNEET, Miner1, and Miner2 were prereduced with dithiothreitol before being exposed to nitric oxide
under anaerobic conditions. When reduced mitoNEET or
Miner1 was treated with a 2-fold excess of nitric oxide (from a
nitric oxide gas-saturated solution), the UV-visible absorption
spectrum of the [2Fe-2S] cluster in mitoNEET (Fig. 2A) or
Miner1 (Fig. 2B) was not significantly changed, indicating that
the [2Fe-2S] cluster in mitoNEET or Miner1 did not interact
with nitric oxide under the experimental conditions. In contrast, when reduced Miner2 was treated with a 2-fold excess of
nitric oxide, a new absorption peak at 422 nm appeared (Fig.
2C). No detectable amount of iron or sulfide was released from
the Miner2 [2Fe-2S] clusters after nitric oxide treatment (data
FEBRUARY 24, 2017 • VOLUME 292 • NUMBER 8
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FIGURE 1. UV-visible and EPR spectra of human mitoNEET, Miner1, and
Miner2. A, UV-visible absorption spectra of purified mitoNEET, Miner1, and
Miner2. MitoNEET, Miner1, and Miner2 were purified as described under
“Experimental Procedures.” Each protein (containing 20 M [2Fe-2S] cluster)
was dissolved in buffer containing NaCl (500 mM) and Tris (20 mM (pH 8.0)).
O.D., optical density. B, EPR spectra of purified human mitoNEET, Miner1, and
Miner2. Each protein (containing 20 M [2Fe-2S] cluster) was dissolved in
buffer containing NaCl (500 mM) and Tris (20 mM (pH 8.0)) and reduced with
dithiothreitol (4 mM) under anaerobic conditions. mT, millitesla. C, EPR spectra
of Miner2. Top spectrum, dithiothreitol-reduced Miner2 [2Fe-2S] clusters. Spectra
1 and 2 were the results of the deconvolution of the top spectrum using simulation software. The g values of the deconvoluted spectra are shown.

not shown), indicating that nitric oxide may bind to the Miner2
[2Fe-2S] clusters without disrupting them. In a control experiment, when reduced apo-Miner2 (Miner2 without the [2Fe-2S]
clusters) was treated with a 2-fold excess of nitric oxide under
anaerobic conditions, no absorption peak at 422 nm was
observed (data not shown), further suggesting that the absorption peak at 422 nm is likely due to the interaction between the
Miner2 [2Fe-2S] clusters and nitric oxide.
Under the same experimental conditions, E. coli SoxR, which
hosts a [2Fe-2S] cluster via four cysteine residues (38), was
treated with a 2-fold excess of nitric oxide under anaerobic
conditions. Fig. 2D shows that the absorption peaks at 414 and
462 nm of the SoxR [2Fe-2S] clusters were largely eliminated,
with no appearance of the absorption peak at 422 nm after
nitric oxide treatment, confirming that the SoxR [2Fe-2S] clusters were disrupted by nitric oxide forming a protein-bound dinitrosyl iron complex, as reported previously (20). Thus, the Miner2
[2Fe-2S] clusters have a unique interaction with nitric oxide.
The Miner2 [2Fe-2S] Clusters Have a Strong Binding Affinity
for Nitric Oxide—To further explore the interaction between
the Miner2 [2Fe-2S] clusters and nitric oxide, Miner2 was preJOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 2. Nitric oxide binding in human mitoNEET, Miner1 and Miner2. A,
purified mitoNEET (containing 20 M [2Fe-2S] cluster) in buffer containing
NaCl (500 mM) and Tris (20 mM (pH 8.0)) was reduced with dithiothreitol (4 mM)
under anaerobic conditions before (spectrum 1) and after (spectrum 2) addition of 40 M nitric oxide anaerobically. O.D., optical density. B, the same as in
A, except purified Miner1 was used. C, the same as in A, except purified Miner2
was used. D, the same as in A, except purified E. coli SoxR was used.

reduced with dithiothreitol, followed by stepwise addition of
nitric oxide under anaerobic conditions. UV-visible absorption
spectra were taken after each addition of nitric oxide. Fig. 3A
shows that, as the nitric oxide concentration increased in the
incubation solution, the absorption peak at 422 nm gradually
increased. The amplitude of the absorption peak at 422 nm was
almost linearly proportional to the nitric oxide concentration in
the incubation solution. An about 2-fold excess of nitric oxide
over Miner2 was sufficient to saturate the nitric oxide binding
in the Miner2 [2Fe-2S] clusters (Fig. 3B), indicating that the
Miner2 [2Fe-2S] clusters have a strong binding affinity for
nitric oxide.
In parallel experiments, after reduced Miner2 was treated
with stepwise addition of nitric oxide under anaerobic conditions, samples were immediately frozen in liquid nitrogen and
subjected to EPR measurements. Fig. 3C shows that, as nitric
oxide concentration increased in the incubation solution, the
EPR signal at g ⫽ 1.92 of the reduced Miner2 [2Fe-2S] clusters
gradually decreased. At 2-fold excess of nitric oxide over
Miner2, the EPR signal at g ⫽ 1.92 was largely eliminated. A
small EPR signal at g ⫽ 2.03, indicative of a protein-bound
dinitrosyl iron complex (26, 28), appeared after the Miner2 was
treated with nitric oxide (Fig. 3C). However, spin quantification
of the EPR signal at g ⫽ 2.04 showed that less than 5% of the
reduced Miner2 [2Fe-2S] clusters might be converted to
the dinitrosyl iron complex, suggesting that the majority of the

3148 JOURNAL OF BIOLOGICAL CHEMISTRY

reduced Miner2 [2Fe-2S] clusters became EPR-silent after
being treated with a 2-fold excess of nitric oxide.
To further test the idea that nitric oxide binds to the Miner2
[2Fe-2S] clusters, the nitric oxide-treated Miner2 was repurified from the incubation solution by passing the protein sample
through a High-Trap desalting column. Repurified Miner2 was
then treated with 0.2 M HCl to release the acid-labile iron and
sulfide from iron-sulfur clusters in the protein. Fig. 3D shows
that more than 80% of the acid-labile iron and sulfide content
remained with Miner2 after being treated with a 2-fold excess
of nitric oxide. Thus, nitric oxide may eliminate the EPR signal
at g ⫽ 1.92 of the reduced Miner2 [2Fe-2S] clusters by directly
binding to the clusters.
Mass Spectrometry Analyses of the Nitric Oxide-bound
Miner2—L-cysteine has been used to release nitric oxide (in the
form of nitrite) from the protein-bound dinitrosyl iron complex
under aerobic conditions (26). To probe the nitric oxide binding in the Miner2 [2Fe-2S] clusters, the nitric oxide-treated
Miner2 was repurified and incubated with L-cysteine at 37 °C
under aerobic conditions for 30 min. Nitrite released from
Miner2 was measured using Griess reagents (26). Fig. 3D shows
that nitrite was indeed released when the nitric oxide-treated
Miner2 was incubated with 10 mM L-cysteine under aerobic
conditions. The ratio of nitrite to total iron in the nitric oxidetreated Miner2 was about 0.41 ⫾ 0.12, indicating that each
[2Fe-2S] cluster in Miner2 binds about one nitric oxide. For
Miner2 without nitric oxide treatment, no detectable amount
of nitrite was observed after incubation with 10 mM L-cysteine.
Mass spectrometry was further used to analyze the nitric
oxide binding in the Miner2 [2Fe-2S] clusters. Fig. 4A shows
that purified Miner2 had a major peak at a molecular weight of
10,878, which is the sum of the expected molecular weight of
apo-Miner2 (10,526) plus 2 ⫻ [2Fe-2S] clusters (352). When
Miner2 was exposed to a 2-fold excess of nitric oxide, the peak
at 10,878 was largely eliminated and replaced with two new
peaks at molecular weights of 10,878 ⫹ 30 and 10,878 ⫹ 60,
respectively (Fig. 4A). As the molecular weight of nitric oxide is
30, two new peaks were assigned to the Miner2 with only one
[2Fe-2S] cluster bound with nitric oxide and the one with both
[2Fe-2S] clusters bound with nitric oxide, respectively. Missing
a nitric oxide in the Miner2 [2Fe-2S] clusters could be because,
during ionization in the mass spectrometry analysis, some
nitric oxide was released from the clusters.
A minor peak at a molecular weight of 10,526 representing
apo-Miner2 was also observed in the same mass spectrum (Fig.
4B). Unlike the major peak at 10,878 (the Miner2 [2Fe-2S] clusters), the minor peak at 10,536 (apo-Miner2) was not changed
after nitric oxide treatment (Fig. 4B), suggesting that apoMiner2 did not bind or react with nitric oxide under the experimental conditions.
A Single Amino Acid Mutation in mitoNEET and Miner1
Facilitates Nitric Oxide Binding in the [2Fe-2S] Cluster—Like
Miner2, mitoNEET and Miner1 contain a CDGSH motif that
hosts a [2Fe-2S] cluster via three cysteine and one histidine
residues (5, 8 –10). However, unlike the reduced Miner2 [2Fe2S] clusters, the reduced mitoNEET [2Fe-2S] cluster or Miner1
[2Fe-2S] cluster fails to bind nitric oxide (Fig. 2, A and B). One
possible explanation is that, in purified mitoNEET and Miner1,
VOLUME 292 • NUMBER 8 • FEBRUARY 24, 2017
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FIGURE 3. The nitric oxide binding activity of Miner2. A, UV-visible absorption spectra of Miner2. Purified Miner2 (containing 20 M [2Fe-2S] cluster) was
prereduced with dithiothreitol (4 mM) under anaerobic conditions, followed by stepwise addition of nitric oxide (from a nitric oxide-saturated solution)
anaerobically. Spectra were taken after each addition of nitric oxide. B, the amplitudes of the absorption peak at 422 nm of the Miner2 [2Fe-2S] clusters were
plotted as a function of the nitric oxide concentrations in incubation solutions. The results are representative of three independent experiments. C, EPR spectra
of Miner2. Purified Miner2 (containing 20 M [2Fe-2S] cluster) was prereduced with dithiothreitol (4 mM) under anaerobic conditions, followed by stepwise
addition of nitric oxide anaerobically. Samples were immediately frozen in liquid nitrogen and subjected to the EPR measurements. mT, millitesla. D, iron,
sulfide, and nitrite content analyses of Miner2. Miner2 was repurified after treatment of a 2-fold excess of nitric oxide under anaerobic conditions. The amounts
of iron, sulfide, and nitrite were measured as described under “Experimental Procedures.” In three different preparations, the iron content in Miner2 varied from
3.5 to 2.0 iron atoms per Miner2. For each preparation of Miner2, the ratio of iron to Miner2 was set to 1.0, and other content was calculated based on the ratio
of iron to Miner2. The amount of nitrite in the Miner2 sample without nitric oxide treatment was not detectable. Data are mean ⫾ S.D. from three experiments.

the protein conformation does not favor nitric oxide binding
to the [2Fe-2S] clusters in the protein. Based on the crystal
structure of mitoNEET (8 –10), the [2Fe-2S] cluster is buried
inside the protein structure, and Asp-96 is in the vicinity of the
[2Fe-2S] cluster and potentially blocks the access of nitric oxide to
the [2Fe-2S] cluster in mitoNEET (supplemental Figs. 2A and 2B).
To test this idea, a mitoNEET mutant in which Asp-96 was
replaced with Val (D96V) was constructed using site-directed
mutagenesis. Fig. 5B shows that the reduced [2Fe-2S] cluster in
the mitoNEET mutant (D96V) could indeed bind nitric oxide
under anaerobic conditions. The mass spectrometry analysis
further revealed that the mitoNEET mutant binds one nitric
oxide per [2Fe-2S] cluster (supplemental Fig. 2C). Similar
results were also observed in the Miner1 mutant in which Asp123 (corresponding to Asp-96 of mitoNEET) was mutated to
FEBRUARY 24, 2017 • VOLUME 292 • NUMBER 8

Val (data not shown). Thus, with a subtle structural change, the
[2Fe-2S] cluster in mitoNEET and Miner1 has a similar nitric
oxide binding activity as the Miner2 [2Fe-2S] clusters.

Discussion
Hemes and iron-sulfur clusters are the major iron-containing co-factors in proteins and are also the primary targets of
nitric oxide (19). Although nitric oxide binding in ferrous heme
iron in proteins has been extensively investigated and well
understood (19, 27), much less has been known about the interactions between nitric oxide and iron-sulfur clusters in proteins. In previous studies, iron-sulfur clusters in proteins were
found to be completely disrupted by nitric oxide forming a protein-bound dinitrosyl iron complex (25–29), thiolate-bridged
di-iron tetranitrosyl complex (30, 31), or octanitrosyl cluster
JOURNAL OF BIOLOGICAL CHEMISTRY
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with dithiothreitol (4 mM) under anaerobic conditions, followed by treatment
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(32), depending on specific proteins and experimental conditions. Such modifications of iron-sulfur clusters by nitric oxide
have also been demonstrated in iron-sulfur cluster model compounds (39, 40). However, in all of these reported examples,
iron-sulfur clusters in proteins are hosted by either all cysteine
residues (33) or Rieske-type two histidine and two cysteine residues (34). Our finding that the reduced CDGSH-type [2Fe-2S]
clusters of human mitochondrial protein Miner2 are able to
bind nitric oxide without disruption of the clusters represents a
new interaction between nitric oxide and iron-sulfur clusters in
proteins. In the CDGSH-type [2Fe-2S] cluster, which is hosted
by three cysteine and one histidine residues, two iron atoms are
asymmetric as one iron is bound by two cysteine residues and
the other by one cysteine and one histidine residues (Fig. 6).
When the [2Fe-2S] cluster is oxidized, both iron atoms in the
cluster are in a ferric state. When the [2Fe-2S] cluster is
reduced, the histidine-bound iron atom will be in a ferrous state
(41). Because nitric oxide prefers to bind ferrous iron (19), we
propose that the ferrous iron in the reduced Miner2 [2Fe-2S]
clusters is likely the nitric oxide binding site (Fig. 6). The
observed absorption peak at 422 nm of the reduced Miner2
[2Fe-2S] clusters after nitric oxide treatment (Fig. 2C) may represent the Soret absorption for the interaction between nitric
oxide and the ferrous iron of the [2Fe-2S] clusters in Miner2. A
similar Soret absorption around 420 nm has been attributed to
nitric oxide binding to the ferrous heme iron in the heme nitric
oxide/oxygen binding protein isolated from Clostridium botulinum (42) and in the thiolate-ligated ferrous cytochrome P450
of the neuronal nitric oxide synthase (43). Binding of nitric
oxide in the Miner2 [2Fe-2S] clusters apparently changes the
redox state of the ferrous iron of the clusters, as binding of nitric
oxide eliminates the EPR signal at g ⫽ 1.92 of the reduced
Miner2 [2Fe-2S] clusters (Fig. 3C). We also noticed that the
interaction between nitric oxide and the Miner2 [2Fe-2S] clusters is stable, as the nitric oxide-bound Miner2 [2Fe-2S] clusters
can be purified and directly observed from the mass spectrometry analysis (Fig. 4A). Although additional spectroscopic studies are needed to further illustrate the nitric oxide binding in the
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Miner2 [2Fe-2S] clusters, we postulate that binding of nitric
oxide in the Miner2 [2Fe-2S] clusters may regulate the function
of the protein in mitochondria.
Unlike the reduced [2Fe-2S] clusters in Miner2, the reduced
[2Fe-2S] cluster in mitoNEET or Miner1 fails to bind nitric
oxide (Fig. 2). Nevertheless, a single mutation of Asp-96 to Val
in mitoNEET facilitates nitric oxide binding in the [2Fe-2S]
cluster (Fig. 5). Similarly, the [2Fe-2S] cluster in the Miner1
mutant with Asp-123 mutated to Val (corresponding to Asp-96
of mitoNEET) can also bind nitric oxide. These results suggest
that a subtle change in protein structure may switch mitoNEET
and Miner1 to facilitate nitric oxide binding in the [2Fe-2S]
clusters. As mitoNEET and Miner1 have specific interactions
with multiple mitochondrial proteins, including the Parkinson’s disease-associated protein Parkin (44, 45), such proteinprotein interactions may well change the conformation of
mitoNEET and Miner1 and facilitate the [2Fe-2S] cluster to
bind nitric oxide. It is also possible that posttranslational
modifications such as phosphorylation and acetylation of
mitoNEET and Miner1 may promote nitric oxide binding in the
[2Fe-2S] cluster. Although both mitoNEET and Miner1 are
considered to be the central regulators for energy metabolism,
iron homeostasis, and production of reactive oxygen species in
mitochondria (13), the specific function of the [2Fe-2S] clusters
in mitoNEET and Miner1 remains largely elusive. Recent studies have suggested that mitoNEET may transfer its [2Fe-2S]
clusters to target proteins in the cytoplasm to promote ironsulfur cluster biogenesis in the cytoplasm (14, 15). Alternatively, mitoNEET may directly regulate mitochondrial functions via redox transition of its [2Fe-2S] clusters (16 –18). In
either case, binding of nitric oxide in the [2Fe-2S] cluster in
mitoNEET or Miner1 could potentially modulate the functions
of these mitochondrial proteins. There are at least 60 more
proteins that may host one or more [2Fe-2S] clusters via three
cysteine and one histidine residues in human cells (46).
Whether the [2Fe-2S] clusters in these newly identified proteins can bind nitric oxide remains to be investigated.
To conclude, human mitochondrial protein Miner2 [2Fe-2S]
clusters can bind nitric oxide without disruption of the clusters.
Although the [2Fe-2S] cluster in purified mitoNEET and
Miner1 fails to bind nitric oxide, a subtle structural change in these
proteins can facilitate nitric oxide binding in the [2Fe-2S] cluster.
Binding of nitric oxide in the CDGSH-type [2Fe-2S] clusters of
mitochondrial proteins may represent a new nitric oxide signaling
mode to modulate mitochondrial functions in human cells.

Experimental Procedures
Protein Preparation—The DNA fragments encoding human
mitochondrial CDGSH-type iron-sulfur proteins (mitoNEET,
containing residues 33–108 (4); Miner1, containing residues
57–135 (5); and Miner2 (containing residues 36 –127)), were
synthesized (Genscript Co.) and cloned into the pET28b⫹ plasmid for expression in E. coli cells. The MitoNEET mutant
and Miner1 mutant were constructed using a site-directed
mutagenesis kit (Agilent Co.). The cloned DNA sequences were
confirmed by direct sequencing (Eurofins MWG Operon).
E. coli cells containing expression plasmids were diluted 1:100
overnight in freshly prepared Luria-Bertani medium and incuVOLUME 292 • NUMBER 8 • FEBRUARY 24, 2017
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FIGURE 5. Nitric oxide binding in the [2Fe-2S] cluster of the mitoNEET mutant D96V. Purified mitoNEET (containing 20 M [2Fe-2S] cluster) in buffer
containing NaCl (500 mM) and Tris (20 mM (pH 8.0)) was reduced with dithiothreitol (4 mM) under anaerobic conditions, followed by stepwise addition of nitric
oxide (from a nitric oxide-saturated solution). Spectra were taken after each addition of nitric oxide. Final concentrations of nitric oxide are shown. O.D., optical
density. B, the same as A, except mitoNEET was replaced with the mitoNEET-D96V in the incubation solutions.
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FIGURE 6. Proposed model for nitric oxide binding in the reduced Miner2
[2Fe-2S] clusters. There are two [2Fe-2S] clusters in each Miner2. The first
[2Fe-2S] cluster hosted by three cysteine and one histidine residues in Miner2
is shown. For the reduced Miner2 [2Fe-2S] cluster, the iron atom bound with
His/Cys residues is in a ferrous state, and nitric oxide binds the ferrous iron in
the [2Fe-2S] cluster.

bated at 37 °C with aeration (250 rpm) for 3 h, followed by
protein induction using isopropyl 1-thio-␤-D-galactopyranoside (100 M) overnight at 18 °C. Apo-Miner2 (Miner2 without
iron-sulfur clusters) was prepared following the same procedures, except 0.5 mM dipyridyl was added to the Luria-Bertani
medium 15 min before isopropyl 1-thio-␤-D-galactopyranoside
was added to induce the expression of Miner2 in E. coli cells.
Protein was purified as described previously (35). The purity of
purified proteins was greater than 95%, as judged by electrophoresis analysis on a 15% polyacrylamide gel containing SDS
followed by staining with Coomassie Blue. The UV-visible
absorption spectra were recorded in a Beckman DU640 UV-visible absorption spectrometer equipped with a temperature controller. The full UV-visible absorption spectrum and SDS-PAGE
of purified human Miner2 are shown in supplemental Fig. 1.
Nitric Oxide Solution Preparation—Nitric oxide gas (Air Co.)
was first passed through a soda-lima column to remove NO2
and higher nitrogen oxides before being used to bubble predegassed water in a sealed 50-ml flask for 5 min. The concentration of nitric oxide in the nitric oxide-saturated solution was
measured using a nitric oxide electrode (World Precision
Instruments) (33). The nitric oxide-releasing reagent diethylamine NONOate (Cayman Chemicals) was also used for preparing nitric oxide solutions. Diethylamine NONOate was first
dissolved in buffer containing Tris (20 mM (pH 10.5)). The
NONOate concentration was determined from the absorption
peak at 250 nm using an extinction coefficient of 6.5
mM⫺1cm⫺1. Diethylamine NONOate releases 1.5 mol of nitric
oxide at a half-life time of 2 min at 37 °C (pH 7.4). Similar results
were obtained when the nitric oxide gas solution or the NONOate solution was used in the experiments.
Iron, Sulfide, and Nitrite Determinations—The total acid-labile iron content in protein samples was determined using an
FEBRUARY 24, 2017 • VOLUME 292 • NUMBER 8

iron indicator, FerroZine, following the procedures described
in Ref. 47. The total acid-labile sulfide content in protein samples was determined following the procedures described by Siegel (48). Nitric oxide bound in Miner2 was released by incubating the protein with 10 mM L-cysteine at 37 °C for 30 min under
aerobic conditions. The total nitrite content in samples was
measured using Griess reagents according to the instructions of
the manufacturer (Cayman Chemicals) (26). The detection
limit of the Griess assay for nitrite was about 1.0 M. The ratios
of iron, sulfide, and nitrite to monomeric Miner2 are presented.
EPR Measurements—The X-band EPR spectra were recorded
using a Bruker model ESR-300 spectrometer equipped with an
Oxford Instruments 910 continuous flow cryostat. Routine EPR
conditions were as follows: microwave frequency, 9.47 GHz;
microwave power, 10.0 milliwatt; modulation frequency, 100
kHz; modulation amplitude, 1.2 millitesla; temperature, 20 K;
receiver gain, 2 ⫻ 105. The EPR spectrum simulation software
was kindly provided by Dr. Evert Duin (Auburn University).
Mass Spectrometry Measurements—All experiments were
performed with an AmaZon speed electron transfer dissociation (ETD) ion trap mass spectrometer (Bruker Daltonics, Billerica, MA). Sample solution was infused via an Apollo II electrospray ion source using a syringe pump at a flow rate of 5 l/min.
MS detection was performed in a full-scan mode in positive ionization-enhanced resolution mode with a scan speed of 8100
m/z/s. The parameter settings for electrospray ionization-mass
spectrometry (ESI-MS) were as follows: capillary voltage, 4500 V;
end plate offset, ⫺500 V; nebulizer, 8 p.s.i.; dry gas, 4 liters/min; dry
gas temperature, 180 °C. MS data were acquired from 300 to 3000
with a target mass of 1500 m/z and trap drive level of 100%. The
software used for data processing and deconvolution was Compass DataAnalysis (Bruker Daltonics).
Author Contributions—Z. C., A. P. L., Y. W., and H. D. designed,
performed, and analyzed the experiments. All authors reviewed the
results and approved the final version of the manuscript.
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